Sequencing Shows How Evolution Can Undermine Bioprocess Commercialization

News   Feb 22, 2018 | Original Story from the Technical University of Denmark

 
Sequencing Shows How Evolution Can Undermine Bioprocess Commercialization

Credit: Boesen Photography & Design/boesenfoto.dk via DTU

 
 
 

RELATED ARTICLES

What an All-Nighter Does to Your Blood

News

Altered sleep and meal timings from pulling an all-nighter just once can disrupt levels and patterns of more than 100 proteins in the blood, including those that influence blood sugar, energy metabolism, and immune function.

READ MORE

PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

News

Investment to fund expansion of operations and progression of drug target pipeline.

READ MORE

Safe Glyphosate Residue Levels in Food Reviewed

News

The EFSA has completed its review of the maximum levels of glyphosate that are legally permitted to be present in food. They found that current exposure levels are not expected to pose a risk to human health.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE